Transfer of Sulfamethazine from Contaminated Beeswax to Honey by Reybroeck, Wim et al.
pubs.acs.org/JAFC Published on Web 05/26/2010 © 2010 American Chemical Society
7258 J. Agric. Food Chem. 2010, 58, 7258–7265
DOI:10.1021/jf1005275
Transfer of Sulfamethazine from Contaminated
Beeswax to Honey
WIM REYBROECK,*,† FRANS J. JACOBS,‡ HUBERT F. DE BRABANDER,§ AND
ELS DAESELEIRE†
†Institute for Agricultural and Fisheries Research (ILVO), Technology and Food Science Unit,
Brusselsesteenweg 370, 9090Melle, Belgium, ‡Department of Biochemistry, Physiology andMicrobiology,
Laboratory for Zoophysiology, Ghent University, Krijgslaan 281 (S33), B-9000 Gent, Belgium, and
§Faculty of Veterinary Medicine, Laboratory of Chemical Analysis, Ghent University, Salisburylaan 133,
9820 Merelbeke, Belgium
A liquid chromatographic tandem mass spectrometric method for the determination of sulfa drugs in
beeswax was developed. When performing residue control on beeswax intended for the fabrication
of wax foundations, residues of sulfonamides were found. A migration test was set up to study
whether sulfonamide-containing beeswax could lead to the contamination of honey. The higher the
concentration of sulfamethazine doped in the wax, the higher was the concentration of sulfametha-
zine found in the honey. The maximum transfer was 15.6, 56.9, and 29.5% of the initial amount
spiked in the wax foundation. In a second experiment, the percentage of sulfamethazine migrating
from medicated winter feed to beeswax in relation to the concentration in the syrup and the contact
time was studied. The maximum transfer of sulfamethazine from medicated sucrose syrup to
beeswax was 3.1%.
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INTRODUCTION
The use of sulfonamides to protect honey bees against bacterial
diseases became a common practice in commercial beekeeping
after Haseman and Childers (1) learned that sulfa drugs, particu-
larly sulfathiazole, could prevent the spread of American foul-
brood (AFB). The compound sulfathiazole provided a short-term
control by suppressing the symptoms of the bee disease caused by
Paenibacillus larvae. It also prevented the reproductive spores
from germinating. The use of sulfa drugs in the bees’ food in the
spring and fall was also encouraged by other authors (2-6).
Despite the effectiveness of sulfonamides against AFB, their
stability and consequent residues in honey caused problems, and
the registration was allowed to lapse in the 1970s (7).
Another important bee pathogen isNosema apis, which causes
nosemosis, the most widespread of all adult honey bee diseases.
Until recently, Nosema apis had been considered to be a micro-
sporidian, a single-celled protozoan, but is now classified as a
fungus or as fungi-related (8). Recently, Nosema ceranae showed
to be widespread in some European regions, afflicting the adult
bees and resulting in depopulation and bee colony losses (9).
The effectiveness of fumagillin, an antibiotic prepared from
Aspergillus flavus, was found tobe effective in 1952byKatznelson
and Jamieson (10). It is commonly used in beekeeping to prevent
and control Nosema disease in several parts of the world. In the
EU, fumagillin is no longer available (11). Some publications or
manuals mention that sulfa drugs can be used against nosemo-
sis (12, 13) or to treat infections due to microsporidia (14-16).
Sulfonamides play an important role as effective chemother-
apeutics for bacterial and protozoal diseases in veterinary med-
icine. They are frequently administered in combination with
dihydrofolate reductase inhibitors of the group of diamino-
pyrimidines (17). In Europe, sulfonamides were classified in
Annex I of Regulation (EEC) 2377/90 with a maximum residue
limit (MRL) fixed at 100 μg kg-1 for the combined residues of all
compounds in the sulfonamide group in meat, fat, liver, and
kidney from all food-producing species (since 1992) and in
bovine, ovine, and caprine milk (since 1994) (18). In the current
legislation, they are classified as allowed substanceswith the same
MRLs (19, 20). However, no MRLs are set for sulfonamides in
honey. As a consequence, a zero tolerance policy regarding
residues of sulfonamides in honey is applied. Some EU member
states established action limits (e.g., Belgium at 20 μg kg-1) (21),
reporting limits (e.g., U.K. at 50 μg kg-1) (22), or tolerance levels
(e.g., Switzerland at 50 μg kg-1) (23) for sulfa drugs. This takes
analytical possibilities and available toxicological data into
account in order to facilitate international trade. The European
community reference laboratory proposed 50 μg kg-1 as the
recommended concentration for the screening of sulfonamides in
honey (24). Despite the lack ofMRLs for sulfonamides in honey,
sulfa drugs could be used in the EU in apiculture based on the
cascade system as described in article 11 of Directive 2001/82/
EC (25), as amended by Directive 2004/28/EC (26). The cascade
systemwas introduced to solve the general problemof availability
*Corresponding author. Tel:þ32 9 272 30 11. Fax:þ32 9 272 30 01.
E-mail: wim.reybroeck@ilvo.vlaanderen.be.
Article J. Agric. Food Chem., Vol. 58, No. 12, 2010 7259
of veterinary medicinal products for minor species. The cascade
system is open to all animal species, including honeybees,
provided that the active substance concerned has been included
in Annex I, II, or III of Regulation (EEC) 2377/90 and the
prescribing veterinarian specifies a withdrawal period (27).
In the framework of a quality program, locally producedhoney
has been examined at ILVO for the presence of residues of
antimicrobials since the year 2000. In the period 2000-2001, 4
out of 248 samples contained streptomycins, 2 out of 72 samples
were positive for tetracyclines, and 3 out of 72 samples had sulfa
drug residues. For the streptomycin and tetracycline contamina-
tion, most cases involved the beekeeper admitting to having
added foreign honey to his production (28). In 2002, sulfa drugs
were found in 3 out of 91 samples. In 2003, 12 out of 203 samples
contained residues of sulfonamides. In most cases, it concerned
sulfamethazine (up to 13000 μg kg-1), and in one case, a
combination of sulfamethazine (458 μg kg-1) and sulfathiazole
(1229 μg kg-1) was found (29). Since 2004, no antimicrobial
residues were found in locally produced honey examined for the
presence of (dihydro)streptomycin, tetracyclines, sulfonamides,
chloramphenicol, macrolides (since 2006), lincosamides (since
2006), and fluoroquinolones (since 2006). This testing occurred in
the framework of the Flemish honey quality program (30 and
unpublished data). Questioning of the beekeeper proved that the
high concentrations found in 2002 and 2003 were caused by the
use of sulfonamides to prevent or to treat nosemosis. However, in
five honey samples, the contamination of sulfonamides was
limited to concentrations below 50 μg kg-1. The five producers
involved all claimed not to have used preparations containing
sulfonamides. External sources of contamination thus needed to
be considered. Other authors reported about the presence of
residues of sulfonamides in honey (23,31-36). In 2008 inEurope,
there were 9 notifications in the RapidAlert System for Food and
Feed (RASFF) from the Directorate-General for Health &
Consumers about residues of sulfonamides in honey (37). It
concerned sulfathiazole in honey from Hungary, Lithuania
(2 notifications), and Portugal, sulfamethazine in honey from
Turkey (3 notifications) and Egypt, and sulfadiazine in honey
from China. In 2009, there was only 1 notification regarding
sulfamethazine in honey from Turkey.
At ILVO, screening of honey samples on the presence of
residues of sulfa drugs is performed by Charm II Sulfonamides
Honey (Charm Sciences Inc., Lawrence, MA). Confirmation of
suspect samples is performed by a liquid chromatographic-
tandem mass spectrometric method validated according to
Commission Decision 2002/657 (38 ) for seven sulfonamides
(sulfapyridine, sulfadiazine, sulfamethoxazole, sulfathiazole, sul-
famerazine, sulfamethazine, and sulfaquinoxaline), using sulfa-
chloropyridazine as internal standard.
Besides honey, beeswax is also an important bee product.
Beeswax is a natural wax produced by the worker bees in their
wax-producingmirror glands on the inner sides of the sternites on
abdominal segments 4 to 7. The newwax scales are masticated by
the worker bees and used to build honeycomb cells in which their
young are raised and honey and pollen are stored. Ripened honey
is also capped with wax. Beeswax is an extremely complex
material that contains over 300 different substances. Its main
components are palmitate, palmitoleic acid, hydroxypalmitate,
and oleate esters of long-chain aliphatic alcohols. Beeswax has a
high melting point, ranging from 61 to 65 C (39). Beeswax is
often contaminatedwith residues of pesticides and acaricides that
then contaminate the honey (40, 41). A liquid chromatographic-
tandemmass spectrometric (LC-MS/MS) method was developed
for the determination of sulfonamides in beeswax. When per-
forming residue control on 10 samples of beeswax intended for
the fabrication ofwax foundations, residues of sulfonamideswere
found in imported beeswax as well as in local beeswax. Crude
beeswax from India contained 325 μg kg-1 sulfadiazine, while
crude Belgian beeswax from hives treated with sulfonamides was
contaminated with 62 μg kg-1 sulfadiazine. In wax from a
honeycomb from a Flemish apiary producing honey contami-
nated with sulfonamides, 14 μg kg-1 sulfamethazine was
found (29). To our knowledge, no studies were performed in
the past to check if sulfa-containing beeswax could lead to
contamination of the honey. We set up a migration test to
investigate this possibility.
A second experiment determined the residue concentration
build up in beeswax after different contact times with sulfa-
medicated syrup.
MATERIALS AND METHODS
Reagents and standards.Sulfapyridine (S-6252), sulfadiazine (S-8626),
sulfamethoxazole (S-7507), sulfathiazole (S-0127), sulfamerazine (S-9001),
sulfamethazine (S-6256), sulfaquinoxaline (S-7382), and sulfachloropyr-
idazine (S-9882, internal standard) all came fromSigma-Aldrich (Bornem,
Belgium). Individual standard stock solutions were prepared by weighing
approximately 5 mg of standard in a glass tube and adding an appropriate
amount of acetonitrile/water (50:50, v/v) to reach a concentration of
1 mg mL-1. Stock solutions were stored at -18 C. Working solution
1, containing the seven sulfa drugs at 10 μg mL-1, was prepared daily by
diluting the stock solutions in a mixture of acetonitrile-water (50:50, v/v).
The composite working solution 2 of 1 μg mL-1 was prepared by diluting
working solution 1 in water.
n-Hexane (082906), acetonitrile (012078),methanol (136878), and formic
acid (069178) came from Biosolve (Valkenswaard, The Netherlands).
Sodium acetate (62648), sodium sulfate (106647), and acetic acid
(1.00063) were fromMerck KGaA (Darmstadt, Germany). Hydrochloric
acid (2 M) (403872) came from Carlo Erba (Milan, Italy). Sodium
hydroxide (B405348019) came from BDH Laboratory Supplies (Poole,
UnitedKingdom). TheMSUextraction buffer came fromCharmSciences
Inc. (Lawrence, MA). Water was HPLC grade (generated by an ELGA
purification system). Filters (Millex GV, 0.22 μm, SLGVX13) for filtra-
tion of the extract were from Millipore (Billerica, MA). Solid phase
extraction columns were Sep-Pak tC18 columns (500 mg, 6 mL,
WAT036790) from Waters (Millford, MA). Syrup was prepared from
ultra grade sucrose (S7903) from Sigma-Aldrich (Bornem, Belgium). A
syrup concentration of 67% w/v (2:1 sucrose/water by weight) was used.
The blank beeswax, obtained from a Flemish hobby beekeeper, had no
evidence of any sulfa drug residue as tested by LC-MS/MS analysis. The
Petri plastic dishes of 14 cm diameter were from Plastiques-Gosselin
(Hazebrouck, France).
Apparatus. The LC-MS/MS system for the honey and beeswax
analyses consisted of an Alliance Separations Module 2695 system from
Waters (Millford, MA) coupled to Quattro LC (triple quadrupole) of
Micromass (Manchester, United Kingdom) equipped with the Z-spray
system. The MS system was controlled by version 3.3 of the MassLynx
software (Waters, Millford, MA). Chromatography for honey and bees-
wax analysis was performed on a XTerra MS C18 column (186000546,
Waters,Millford,MA). The column (particle size 5 μm, 150mm 2.1mm
i.d.) was protected by a guard column containing the same material.
The following small lab equipments were used: a shaking device KS250
from IKA Werke GmbH & Co.KG (Staufen, Germany), a centrifuge
Centra-CL3 from Thermo IEC (Needham Heights, MA), an incubator
BD240 with natural convection from Binder GmbH (Tittlingen,
Germany), a water bath and heating circulator from Julabo Labortechnik
GmbH (Seelbach, Germany), and an ultrasonic bath Branson 2200 Ultra-
sonic Cleaner from Branson Ultrasonics Corporation (Danbury, CT).
Sample Preparation. For honey, the cleanup was based on the
method described by Maudens et al. (44). Honey was homogenized by
manual stirring. An aliquot of 1.5 g of the homogenized honey sample was
weighed in a centrifuge tube of 50 mL. At this stage,, 50 μg/kg of
sulfachloropyridazine (Internal Standard) was added, and the sample
was allowed to stand for 20min.After the addition of 1.5mLof a 2MHCl
solution, we placed the tube in a shaking device for 30 min. After
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adjustment of the pH to 5.0with 550μLof 5MNaOHand 750μLof 1.2M
sodiumacetate,we added 8mLof acetonitrile andplaced the tube again on
the shaking device for 30 min. After centrifugation for 30 min at 1800
RCF, we decanted the upper layer into a second centrifuge tube and added
5 g of sodium acetate. After shaking during 5 min, we centrifuged the
tube for 10 min at 1800 RCF and transferred the liquid layer to a glass
tube. The extract was evaporated under nitrogen in a water bath of 45 C.
The residue was dissolved in 2 mL of a 1% acetic acid solution, and the
tubewas placed for 5min in anultrasonic bath. Solid phase extraction columns
(SPEC18) were conditionedwith 5mLofmethanol and 2 5mLofwater.
The honey extract was brought onto the column and was allowed to flow
through the columnat a slow flow rate. The columnwaswashedwith 5mL
of water, and after drying, we eluted the sulfonamides from the column
with 1.3 mL of methanol. The extract was evaporated under nitrogen in a
water bath of 45 C. The extract was dissolved in 500 μL of the mixture of
acetonitrile/water (50:50, v/v) and 0.1% formic acid, and after filtration,
we brought the extract into a HPLC vial and injected 40 μL into the
LC-MS/MS system. With each series of samples, a blank sample, samples
spiked at 2, 5, 10, 20, 50, and 100 μg kg-1 sulfamethazine (calibration
curve), and a second line control sample (spiked by the laboratory
responsible or by another technician) were analyzed.
Beeswax Preparation.Five grams of beeswax, cut into small pieces, was
weighed in a centrifuge tube of 50 mL. After the addition of 200 μg kg-1
sulfachloropyridazine as internal standard, we dissolved the beeswax in
30 mL of hexane by shaking on a shaking device at 500 rpm. Afterward,
20 mL of MSU extraction buffer was added. The tube was manually
shaken for 2 min, sonicated for 5 min in an ultrasonic bath, and again
manually shaken for 2 min. After centrifugation for 10 min at 2850 RCF,
we discarded the supernatant and transferred the water phase to another
centrifuge tube of 50mL.The solid phase extraction column (SPEC18) was
conditioned with 5 mL of methanol and 2  5 mL of HPLC water. The
extract was allowed to flow through the column at a slow flow rate. The
column was washed with 5 mL of water, and after drying, we eluted the
sulfonamides from the column with 2.5 mL of methanol. The methanol
was evaporated under nitrogen at 45 C, and the residues were dissolved in
500 μL of acetonitrile/water (50:50, v/v) containing 0.1% formic acid, and
after filtration,we brought the extract into aHPLCvial and injected 40 μL
into the LC-MS/MS system. With each series of samples, a blank sample,
samples spiked at 100, 200, 500, 750, and 1000 μg kg-1 sulfamethazine
(calibration curve), and a second line control sample were analyzed.
LC-MS/MS Analyses. The LC separation was performed on a
reversed-phase column with an organic mobile phase. The mobile phase
consisted of water (A) and acetonitrile (B), both containing 0.1% formic
acid. The gradient conditions were as follows: from 0 to 0.5 min, held
100%A; ramped over 0.1 min to 55%A and 45%B; ramped over 7.9 min
to 35% A and 65% B; ramped over 0.1 min to 100% B; held for 10 min;
ramped over 1.4 min to 100%A; held 100%A for 10 min to reequilibrate
the system. The flow rate was 0.25 mL/min. The abundant parent ions
[M þ H]þ produced by positive electrospray ionization were selected for
collisional dissociation with argon. When analyzing honey or beeswax
from unknown origin, for each of the 7 sulfa drugs the transition of the
precursor ion into at least two product ions was followed in multiple
reaction monitoring in order to obtain enough identification points, as
required inCommissionDecision 2002/657/EC (38). All compounds could
be detected in one run. A summary of the cone voltages, collision energies,
precursor and product ions, and retention times of the 7 compounds is
presented in Table 1.
The Quattro LCZ mass spectrometer was operated in ESI-MS/MS
positive ionmode. High-purity nitrogenwas used as drying gas and as ESI
nebulizing gas. Argon was used as collision gas to obtain product ions.
Dwell time and interchannel delay were optimizedwith standard solutions
andwere set at 0.5 and 0.03, respectively. The source block anddesolvation
temperature were set at 120 and 300 C, respectively.
Calculation of Partition Coefficients. The partition coefficient of
some sulfonamides was calculated using Advanced Chemistry Develop-
ment (ACD/Laboratories) Software, version 8.14 (1994-2010 ACD/
Laboratories, Toronto, Canada).
Experiments and Sampling. In a first experiment, we placed sulfa-
methazine-containing wax foundations in beehives in order to see whether
this practice could lead to contamination of the produced honey. A wax
foundation is a thin sheet of beeswax that is embossed with the hexagonal
shape that the bees naturally form for their honeycomb.The bees draw out
the combbyaddingwax on topof the foundation to create hexagonal cells,
where the honey and pollen are stored, and the eggs are laid by the queen.
In general, beekeepers buy the wax foundations at a beekeepers’ shop. The
wax foundations for the experiment were made by molding wax by means
of negative silicone templates of a beeswax sheet, pouring hot wax of 80 C
into it and closing the mold and allowing the wax to cool. To prepare
sulfamethazine-containing wax foundations, liquid blank beeswax was
spiked with sulfamethazine at three different levels, namely, 1, 10, and
100mg kg-1. Sulfamethazine was dissolved in 5mL ofmethanol, added to
120 g of liquid beeswax, and mixed by hand with a stainless steel stirrer.
After molding, a small amount of each wax foundation was sampled for
sulfamethazine residue analysis by LC-MS/MS. The spiked wax founda-
tions were placed in rectangular wooden frames with wires across the
vertical center to hold the wax foundations in place. In mid-June, the start
of the summer blossoming season, each frame with a spiked wax founda-
tion was placed close to the brood nest in a different hive of the
experimental apiary of UGent, to let the honeybees (Apis mellifera L.)
draw out the spiked wax foundation to honeycomb. The three free-flying
colonies were housed in double brood boxes with 11 Simplex standard
frames (34.0 cm by 19.6 cm of comb; 2.3 cm thickness of the wooden
frame) and one super box. After 1 week, the frames were transferred to the
super box of the hives to prevent the queen from laying eggs in the combs.
The supers were separated from the rest of the hives by a queen excluder.
At four weeks from the start, the combs contained capped honey, and the
frames were removed from the hives for a first sampling of honey. The
honeycombs were further incubated for 3 months in the laboratory in an
incubator with natural convection at 35 C, corresponding to the tem-
perature in the hive, and sampled monthly. The sampling of honey was
performed by spooning from both sides of the comb. In the sampled
honey, the quantity of sulfamethazine was determined by LC-MS/MS.
Honey was also sampled from other frames present in the supers of the
hives participating in the trial. These control samples were analyzed on
the presence of residues of sulfonamides. Before analysis, honey and wax
were separated by sieving at a temperature of 30-35 C to prevent inter-
ference by small wax particles present in the honey.
A second experiment investigated the possible level of contamination of
beeswax caused by transfer from medicated syrup solution. Large Petri
dishes were filled with 30 mL (= 29 g) of blank beeswax. Winter feed
solution of 67%w/v sucrose was prepared and spikedwith sulfamethazine
at three different concentrations, namely, 30, 150, and 750 mg L-1.
In each Petri dish, 50 mL of medicated syrup was poured on top of the
0.2 mm layer of beeswax, the plates were closed and sealed to prevent
Table 1. Summary of Tuning and Chromatographic Parameters for
Honey Analysis
compound
precursor
ion (m/z)
cone
voltage (V)
product
ions (m/z)
collision
energy (eV)
retention
time (min)
sulfamethazine 279.06 35 155.94 20 7.57
91.99a 30
124.15 27
sulfapyridine 250.00 30 156.00a 15 7.35
92.10 28
108.00 25
sulfadiazine 250.94 27 156.06a 16 7.35
92.18 25
107.95 22
sulfamethoxazole 253.97 24 156.10 15 8.21
91.99a 25
108.07 25
sulfathiazole 256.07 26 156.19 15 7.28
92.11a 27
107.95 25
sulfamerazine 265.10 25 156.04a 17 7.50
92.01 28
108.00 25
sulfaquinoxaline 301.07 25 156.18a 17 8.49
92.00 30
108.04 28
sulfachloropyridazine 285.02 27 156.00 15 7.99
aMost abundant product ion.
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evaporation, and placed undisturbed in an incubator at 35 C for 3
months. After 14 days, 1, 2, and 3months, we opened four Petri dishes per
sulfamethazine concentration. The syrup was discarded, and the beeswax
was thoroughly washed with distilled water and dried with absorbent
paper. The amount of sulfamethazine in the wax samples was determined
by LC-MS/MS.
RESULTS AND DISCUSSION
For the 7 sulfa drugs tested in honey, the decision limit (CCR)
was e2 μg kg-1, and depending on the type of sulfa drug, the
detection capability (CCβ) was in the range of 2.2-2.4 μg kg-1.
Themean value, standard deviation, and coefficient of variation for
six blank honey samples spiked at 2 μg kg-1(CCR) and 4 μg kg-1
(2 CCR) were determined. The results are given in Table 2.
The decision limit (CCR) for sulfamethazine and sulfadiazine
in beeswax was 20 μg kg-1; the detection capability (CCβ) was
25 μg kg-1. Themean value, standard deviation, and coefficient of
variation for four blank beeswax samples spiked at 25 and
100 μg kg-1 were calculated. The results are summarized inTable 2.
All residue analyseswere performed at ILVO. Since the spiking
with sulfamethazine took place in heated liquid beeswax at 80 C,
leading to a certain degradation of the sulfa drug, parts of the
spiked wax foundations were analyzed by LC-MS/MS to deter-
mine the concentration of sulfamethazine in the wax foundations.
Figure 1 shows the chromatogram of the detection of sulfametha-
zine in the wax foundation of combB, 100 times diluted. The wax
foundations used in the migration experiment contained 590 (A),
3760 (B), and 73000 (C) μg kg-1 sulfamethazine. This indicates
Table 2. Mean Value (in μg kg-1), Standard Deviation (SD, in μg kg-1), and Coefficient of Variation (V.C., in %) for the Determination of Sulfonamides in Honey
(n = 6) at 2 and 4 μg kg-1 and for the Analysis of Sulfamethazine in Beeswax (n = 4) at 25 and 100 μg kg-1
honey
honey spiked at 2 μg kg-1 honey spiked at 4 μg kg-1
compound mean (μg kg-1) SD (μg kg-1) V.C. (%) mean (μg kg-1) SD (μg kg-1) V.C. (%)
sulfamethazine 2.00 0.14 7.00 4.27 0.17 3.92
sulfapyridine 2.09 0.08 3.85 4.11 0.19 4.64
sulfadiazine 2.02 0.16 8.04 4.07 0.13 3.31
sulfamethoxazole 2.08 0.07 3.43 4.10 0.24 5.88
sulfathiazole 2.01 0.25 12.23 3.97 0.22 5.49
sulfamerazine 2.07 0.09 4.47 4.24 0.11 2.48
sulfaquinoxaline 2.00 0.14 7.00 4.10 0.12 3.00
Beeswax
wax spiked at 25 μg kg-1 wax spiked at 100 μg kg-1
compound mean (μg kg-1) SD (μg kg-1) V.C. (%) mean (μg kg-1) SD (μg kg-1) V.C. (%)
sulfamethazine 26.90 0.86 3.20 117.57 8.46 7.19
Figure 1. Chromatogram of the wax foundation of comb B, 100 times diluted. x axis, retention time in min; y axis, abundance (%). Sulfachloropyridazine =
internal standard.
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that 41, 62, and 27% of the initial spiked concentration, respec-
tively, was lost due to heat degradation. The differences in
degradation could possibly be explained by the longer time spent
tomold the wax foundation spiked at 10mgkg-1 sulfamethazine.
The weight of a wax foundation was approximately 60 g; hence,
the total amount of sulfamethazine present in the wax founda-
tions was 35, 226, and 4380 μg, respectively.
The results of the migration of sulfamethazine to the honey
during storageof thehoney in the combsare shown inTable 3. The
higher the concentration of sulfamethazine in the wax, the more
residues were found in the honey. Migration of residues from
the beeswax to the honey in combs B andC was still continuing in
the first month of storage of the frames in the incubator. From
the second sampling on, rather steady residue values were found
in the honey. A level of 590 μg kg-1 sulfamethazine in the wax
foundation resulted inmeasurable contaminations in honey, while
3760 μg kg-1 sulfamethazine in the wax foundation resulted in
sulfamethazine contaminations in honey, surpassing the recom-
mended concentration for the screening of 50 μg kg-1 as proposed
by EU Community Reference Laboratory. The control honey
samples from hives A and B were free of sulfa residues, while
4 μg kg-1 of sulfamethazine was found in the control sample from
the third hive. The control honey results excluded external sources
of contamination and indicated that the sulfamethazine in the
honey samples fully originated from the spiked beeswax. Regard-
ing the low contamination of 4 μg kg-1 of sulfamethazine in
the comb of hive C, it is known that bees always recuperate and
move material. Therefore, it is possible that bees of that hive were
transferring small quantities of contaminated honey to other
honeycombs in the same super.
The sampling of honey by spooning was always performed at
places where the comb was fully built out by the bees to the
thickness of the wooden frame (2.3 cm) and filled with capped
honey. A frame completely filled with honey contained approxi-
mately 1.84 kg of honey. At all sampling sites on the comb, the
wax/honey ratio was consequently always 60 g:1.84 kg. When
these conditions (60 g of wax foundation and 1.84 kg of honey)
were taken into account, themaximumamount of sulfamethazine
thatmigrated from the three spikedwax foundations to the honey
was 15.6, 56.9, and 29.5%. These figures show that sulfametha-
zine is not so lipophilic and is quite easily released from thewax to
migrate to the honey in the combs. In our experiment, we used
sulfamethazine since this sulfonamide was the most commonly
identified in Flemish honey. The probability that other sulfona-
mides also transfer from contaminated beeswax to honey is very
high. The percentage of transfer is dependent on the lipophilicity
of the substance. The octanol/water partition coefficient for some
sulfa drugs was calculated with specialized software. The log P
values or the logarithm of the ratio of the concentrations of the
un-ionized sulfa drugs in the solvents water and octanol are
shown inTable 4. Chemicalswith low logP values (e.g., less than 1)
may be considered relatively hydrophilic; conversely, chemicals
with high log P values (e.g., greater than 4) are very hydrophobic.
The log P value for sulfamethazine (0.803, relatively hydrophilic)
explains the high percentages of transfer of sulfamethazine from
beeswax to honey. In comparison to sulfamethazine, sulfamethox-
azole, sulfaquinoxaline, and sulfachloropyridazine are somewhat
more lipophilic, while sulfapyridine, sulfadiazine, sulfathiazole,
and sulfamerazine are more hydrophilic.
The transfer results of the in vivo experiment indicate that the
purchase and the use of contaminated wax foundations by the
beekeeper can lead to low-level sulfonamide contaminations in
honey. Beekeepers can be advised to recycle their own beeswax
for the fabrication of the wax foundations or to ask for a
certificate when buying wax foundations from wax transforming
factories that mostly use wax from unknown origins. Under
practical conditions, wax is recycled from different types of comb
material, namely, brood combs, honeycombs, and cappings. At
wax transforming factories, a single lot of highly contaminated
wax could cause a high residual concentration in all resulting
foundations (45). The use of a synthetic foundation wax such as
Syncera (46) could also be an effective alternative. Fully drawn
plastic foundations, with the hexagonal worker cells embedded in
the plastic, are also available. This study also indicates that in case
authorities are considering a zero-tolerance for antimicrobial
residues in honey, beekeepers could lose their honey production
just by using wax foundations bought in the market. The use of
action limits could be an answer to this problem.
However, not all cases of low-level sulfonamide contamination
in Flemish honey can be claimed to be caused by the use of sulfa-
contaminated wax foundations. Other sources of sulfonamide
contamination could be the robbery by bees of contaminated
honey fromhives of other apiaries (47), the feeding of sulfonamide-
contaminated honey to bee colonies by the beekeeper, and the
mixing of privately produced honey with external honey of
Table 3. Concentration (inμg kg-1) and Amount (inμg) of Sulfamethazine in Honey and Percentage of Transfer (in %) of Sulfamethazine from Beeswax at Different
Sampling Dates (n = 1)a
sulfamethazine concentration (μg kg-1) in honey sulfamethazine (μg) in honey transfer (%) of sulfamethazine
time after start of experiment comb A comb B comb C comb A comb B comb C comb A comb B comb C
1 month <2 10 176 <4 18 323 <10.4 8.1 7.4
2 months 3 52 628 6 95 1152 15.6 42.3 26.3
3 months 2 58 704 4 106 1292 10.4 47.2 29.5
4 months 3 70 605 6 128 1110 15.6 56.9 25.3
hive A hive B hive C
control comb <2 <2 4
aCombs A, B, and C with 590, 3760, and 73000 μg kg-1 sulfamethazine in the wax foundation, respectively. Percentages of transfer are based on 60 g of wax foundation and
1.835 kg of honey per comb. Concentration (in μg kg-1) of sulfamethazine in honey sampled from the control combs with residue-free beeswax from the beehives involved in the
transfer experiment.
Table 4. log P Values for Some Sulfa Drugs
compound CAS number log P
sulfamethazine 57-68-1 0.803( 0.259
sulfapyridine 144-83-2 0.034( 0.318
sulfadiazine 68-35-9 -0.117 ( 0.255
sulfamethoxazole 723-46-6 0.887( 0.419
sulfathiazole 72-14-0 0.047( 0.396
sulfamerazine 127-79-7 0.343( 0.257
sulfaquinoxaline 59-40-5 1.305( 0.385
sulfachloropyridazine 80-32-0 1.018 ( 0.622
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dubious quality. There is also the possibility that the source of
contamination with sulfonamides is related to agricultural prac-
tices, e.g., bees can collect sulfa-medicated drinking water from
poultry farms, rabbit cages, or race-pigeon lofts. The manure of
animals (pigs/cows) treated with sulfonamides or sulfa-containing
surface water could also be the vector (48). In the case of the
low contamination of Flemish honey, the link to agriculture
cannot be completely ruled out. However, it is considered to be
rather unlikely for some sulfa drugs without registration in
Belgium, e.g., sulfamethazine. Contamination of honey with
residues of sulfanilamide could also be caused by the collection
by bees of nectar from meadows treated with the herbicide
asulam. Such honey is contaminated not only by asulam but also
by its degradation product sulfanilamide (35).
Beeswax and propolis are most likely to be contaminated with
synthetic acaricides since varroacides have to be used for long-
term Varroa destructor control. Synthetic acaricides such as
bromopropylate, coumaphos, fluvalinate, and flumethrin are
mostly fat-soluble and persist in wax. After acaricide treatments,
they accumulate in wax and contaminate honey to a much lesser
extent (49, 50). The rate of transfer of acaricides to honey is
directly related to their lipophilicity. Recycling of wax by melting
of combs has no degradation effect on acaricide concentra-
tion (50). The use of CheckMiteþ (coumaphos) for the chemical
treatment of the small hive beetle (Aethina tumida) even results in
higher residue levels in wax and honey than those found after the
use of coumaphos against Varroa (51). para-Dichlorobenzene
and naphthalene are sometimes used for wax moth (Galleria
mellonella and Achroia grisella) control. These practices result in
residues of these compounds in the wax and honey (41). But the
experiment described here is the first to report that contaminated
beeswax could be the vector of honey contamination with
antimicrobial residues. There is a high persistence of sulfonamide
residues in honey and in beeswax inside the hive. In 1950, a patent
was given to the invention of bee comb foundation with sul-
fathiazole incorporated in the beeswax to protect the hives against
American foulbrood (52). Sulfa drugs are known to remain
effective at a hive temperature of 34 C for at least 3 years (53).
No information was available on the persistence of sulfa drugs in
recycled beeswax. The persistence depends on the lipophilicity of
the substances and their stability at temperatures above the
melting point of beeswax. In our experiment, beeswax wasmelted
on a hot plate at 80 C, and amaximum loss of 62%was stated. In
wax transforming factories where large amounts of beeswax are
melted, the heating timewill bemuch longer than the time applied
for the molding of the three spiked wax foundations in our
experiment. However, there are serious indications that remelting
of wax is not eliminating all sulfa residues.
To check as towhat extent the beeswax can be contaminatedby
the application of sulfa drugs, we investigated the transfer
from medicated syrup solution to blank beeswax in an in vitro
experiment. The migration of sulfamethazine to beeswax from 3
syrup solutions with a different sulfamethazine concentration
was followed for 3 months. The results of the sulfamethazine
concentrations measured by LC-MS/MS in the beeswax after 14
days, 1, 2, and 3 months of contact with 50 mL of medicated
sucrose syrup are summarized in Table 5. A concentration of 30
mg kg-1 sulfamethazine in the syrup resulted in a maximum
sulfamethazine concentration of 115 μg kg-1 in the beeswax, and
a plateau was reached after 2 weeks of contact. Concentrations of
150 and 750 mg kg-1 sulfamethazine in the syrup resulted in
maximum 8000 and 24000 μg kg-1 sulfamethazine in the bees-
wax, respectively. The maximum level was reached after 2 and 3
months of contact, respectively. The total amount of sulfametha-
zine in the syrup on top of the wax was 1.5 mg (syrup A), 7.5 mg
(syrup B), and 37.5 mg (syrup C), respectively. The maximal
amount of sulfamethazine transferred was 3, 232, and 696 μg or
0.2, 3.1, and 1.9%, respectively. There is no direct explanation for
the rather big differences in transfer percentages. As could be
expected for the rather hydrophilic sulfamethazine (log P =
0.803), these data indicate that beeswax has a certain ability to
retain sulfamethazine. On the basis of the log P values mentioned
in Table 4, the same could be supposed for other sulfa drugs.
InEurope, the provision ofwinter feed is normally given by the
beekeepers before the end of September. This feed is stored by the
bees in the combs and will be consumed during wintertime and in
spring. The contact time is in practice as long as or even longer
than the three months applied in the experiment. Mutinelli (54)
mentions an application of sulfathiazole in USA against Eur-
opean foulbrood. During three gorging treatments at 4 to 5 day
intervals, they administeredmedicated syrup containing 265mgL-1
sulfathiazole (equivalent to 1 g of sulfathiazole per gallon). This is
in the range of concentrations applied in the experiment. In
reality, the ratio of volume of stored syrup in capped cells in
relation to the weight of beeswax is much higher than the ratio of
50mL:29 g in the experiment. Therefore, in reality higher transfer
percentages could be expected.
This experiment indicates that after application of sulfametha-
zine, high concentrations of sulfamethazine residues can be expec-
ted in the wax. This is likely to be the case for other sulfa drugs as
well. However, the monitoring data reveal rather low sulfa concen-
trations (62 and 325 μg kg-1 of sulfadiazine in bulk beeswax and
only 14 μg kg-1 of sulfamethazine in wax from a honeycomb of a
hive with the production of sulfa-contaminated honey). A possible
explanation could be that the contaminated beeswax is largely dilu-
tedbypure beeswax coming fromdifferent apiaries.Concerning the
wax of the individual honeycomb, there is no certainty that this
combwas already present in the hive during sulfa application in the
winter feedof theprevious year. It is possible that the comb sampled
in summer originated from a wax foundation given in spring.
Conclusions. The presence of residues of sulfonamides in
beeswax was confirmed by a newly developed LC-MS/MS
method. A migration experiment followed the transfer of sulfa-
methazine from beeswax to honey. The higher the concentration
of sulfamethazine doped in the wax, the higher was the concen-
tration of sulfamethazine found in the honey. The maximum
Table 5. Concentration (in μg kg-1) and Amount (in μg) of Sulfamethazine in 30 mL of Beeswax and Percentage of Transfer (in %) of Sulfamethazine from Syrup to
Blank Beeswax after 14 days, 1, 2, and 3 Months of Contact with 50 mL of Medicated Syrup Solution (n = 1)a
sulfamethazine concentration (μg kg-1) in beeswax sulfamethazine (μg) in beeswax transfer (%) of sulfamethazine
incubation syrup A syrup B syrup C syrup A syrup B syrup C syrup A syrup B syrup C
14 days 109 500 2000 3 15 58 0.2 0.2 0.2
1 month 115 2000 5000 3 58 145 0.2 0.8 0.4
2 months 96 8000 6000 3 232 174 0.2 3.1 0.5
3 months 101 7000 24000 3 203 696 0.2 2.7 1.9
aSyrups A, B, and C were spiked with 30000, 150000, and 750000 μg L-1 sulfamethazine, respectively.
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transfer was 15.6, 56.9, and 29.5%, respectively, of the initial
amount spiked in the wax foundation.
A second in vitro experiment determined the percentage of
sulfamethazine migrating frommedicated winter feed to beeswax
in relation to the concentration in the syrup and the contact time.
Themaximum transfer of sulfamethazine frommedicated sucrose
syrup to beeswax was 3.1%. The higher the concentration of
sulfamethazine doped in the syrup, the longer it takes to get the
highest percentage of transfer.
The results of both experiments indicate that after the use of
sulfonamides in the hive, a pool of residues remains in the wax of
the combs. Residues remaining in the beeswax can contaminate
the honey during the next honey season. Therefore, the harvest
and destruction of the first honey production are not sufficient
measures to guarantee residue-free honey in later productions.
Especially in the countries without tolerance levels for sulfa drugs
inhoney, low concentrations of sulfonamides in honey could have
serious implications. Our findings also imply that veterinarians
prescribing sulfonamides in apiculture based on the cascade
systemmay find it difficult to indicate withdrawal periods. These
consequences should also be kept in mind should the European
Commission choose to fix MRLs for anti-infectious agents in
honey. The results also indicate serious implications regarding the
recycling of beeswax.
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